Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from JBM (Healthcare) Ltd. ( (HK:2161) ) is now available.
JBM (Healthcare) Limited has announced a positive profit alert, expecting a significant increase in consolidated profit by at least 50% for the year ending March 31, 2025, compared to the previous year. This growth is attributed to strong sales performance driven by effective brand management and marketing strategies, highlighting the company’s successful positioning in the consumer healthcare market.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited operates in the healthcare industry, focusing on branded and proprietary Chinese medicines. The company’s key products include Ho Chai Kung, Po Chai Pills, and Flying Eagle Woodlok Oil, with a market focus on Hong Kong, Macau, and the Greater Bay Area.
Average Trading Volume: 1,120,067
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.74B
See more data about 2161 stock on TipRanks’ Stock Analysis page.